FDA Tells Congress To Deal With CBD - Nothingbuthemp
The regulatory agency announced that it would be handing the headache of regulating the CBD industry off to Congress, citing insufficient safety standards. As reported by numerous media outlets , the U.S. Food and Drug Administration (FDA) released a statement on Thursday announcing that it would no longer be regulating products containing the hemp-derived cannabinoid CBD. In that statement, the agency said there needs to be more information about the safety of CBD products to properly regulate them as foods or supplements under the FDA's current structure. In a statement, FDA Deputy Commissioner Janet Woodcock said, "A new regulatory pathway would benefit consumers by providing safeguards and oversight to manage and minimize risks related to CBD products." "A new regulatory pathway would benefit consumers by providing safeguards and oversight to manage and minimize risks related to CBD products." - FDA Deputy Commissioner Janet Woodcock The announcement c...